MedicalDevice Licensing.com
Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

About Us
Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd
UTEK Corporation
Press releases

Stay current with the latest press releases from within the industry.

New enteral nutrition production plant in Chile

Release issued 9th May 2006

Santiago de Chile. B. Braun Medical Chile S.A. has inaugurated a new production plant for enteral nutrion on April 25, 2006. The new factory is the first B. Braun Excellence Center for the manufacture of enteral diets worldwide. B. Braun invested € 3,5m into the construction of the new factory. 136 employees work for B. Braun Medical Chile.

"I am very happy and proud to have achieved this dream", said General Manager Roberto Oetiker at the official inauguration event. "Our next steps are to continue developing products which will completely satisfy the demanding quality norms of global economy."

B. Braun Chile has been active in the field of enteral nutrition for a long time and is now looking back on 23 years of absolute leadership on this line in the Chilean market. After hard work in unison with experts in nutrition and health areas from public and private universities, ADN (Alimento Dietético Nutricional, produced in Chile) was developed in 1983, i.e. ADN (Nutritional Diet Food), which would widely satisfy the national market for this line of products was possible.

To date B. Braun Chile has an important variety of formulas with excellent organoleptic tolerance including polymeric formulas such as Nutricomp ADN, ADN Fibre, and Modular formulas such as Calcium Caseinate and Caloric Module. The line is completed by special formulas such as Diabetic ADN, Pediatric ADN and Renal ADN.

These enteral products are the basis of hospital clinical nutrition and are very adequately complemented with the nutritional parenteral line, where B. Braun is internationally recognized. B. Braun Chile is currently successfully exporting Nutricomp ADN in its different presentations to Argentina, Brazil, Bolivia, Cuba, Ecuador, Paraguay, Peru, Venezuela, Asia-Pacific and Russia.

Adequate nutrition plays an important role in maintaining optimal health and improving clinical outcome. Investigations have shown that up to 40% of the patients in hospitals are malnourished. Thus, nutritional support is an essential element of treatment for patients not only in hospitals, but also in nursing homes and alternate site care. Enteral nutrition support is needed if the patient is unable, not allowed or not willing to take adequate nutrition from normal food.

Company details

If you want to find out more about the company visit B. Braun Melsungen AG profile.

Latest B. Braun Melsungen AG press releases

More Press Releases

Related categories

Industry sector
Pharmaceutical
Nutrition
Service
Manufacturing

Clients in focus...

Get the Flash Player to see this rotator.

Partnering discussion free of charge
BioPartnering America
Press releases: Pharmalicensing current industry press releases.

© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd UTEK Corporation All rights reserved. Terms and Conditions | Contact us